Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FAVWB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,526
Award facts
- Contract value 100% obligated
- $31,525.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,525.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, operates under firm fixed-price terms with no set-aside designation. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Enbrel is a biologic immunosuppressant medication used to treat rheumatoid arthritis, psoriasis, and other autoimmune conditions, making this delivery order part of DLA's ongoing efforts to maintain pharmaceutical inventory across Department of Defense medical treatment facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of branded and generic medications, biologics, and medical consumables distributed primarily through its SPE2DB IDC program. The firm's status as a woman-owned small business enables it to compete effectively in federal procurement markets while providing direct distribution of specialty pharmaceutical products to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FAVWB?
SPE2DB25FAVWB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FAVWB worth?
The government has obligated $31,526 on SPE2DB25FAVWB.
Is contract SPE2DB25FAVWB an order under another contract?
Yes. SPE2DB25FAVWB is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVWB competed?
The extent of competition for SPE2DB25FAVWB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award